BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 859203)

  • 1. Radioisotope bone scanning characteristics of metastatic skeletal deposits of prostatic adenocarcinoma.
    Kane RD; Paulson DF
    J Urol; 1977 May; 117(5):618-21. PubMed ID: 859203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absent or faint renal uptake on bone scan. Etiology and significance in metastatic bone disease.
    Kim SE; Kim DY; Lee DS; Chung JK; Lee MC; Koh CS
    Clin Nucl Med; 1991 Aug; 16(8):545-9. PubMed ID: 1934804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistent Superscan and Lincoln Sign on Bone Scintigraphy.
    Kulkarni M; Soni A; Shetkar S; Amer M; Mulavekar A; Joshi P
    Clin Nucl Med; 2017 Aug; 42(8):630-632. PubMed ID: 28525460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [X-ray survey and radioisotope scanning of the skeleton in the evaluation of bone metastases in prostatic carcinoma].
    Meiraz D; Garti I; Lubin E
    Harefuah; 1978 Nov; 95(10):332-3. PubMed ID: 570535
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation of strontium-85 photoscanning with skeletal x-ray surveys in patients with carcinoma of the prostate.
    Johnson DE; Haynie TP
    J Surg Oncol; 1972; 4(2):102-8. PubMed ID: 5033029
    [No Abstract]   [Full Text] [Related]  

  • 6. False negative bone scans in disseminated metastatic disease.
    Thrupkaew AK; Henkin RE; Quinn JL
    Radiology; 1974 Nov; 113(2):383-6. PubMed ID: 4419062
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone scan patterns of patients with diffuse metastatic carcinoma of the axial skeleton.
    Witherspoon LR; Blonde L; Shuler SE; McBurney DB
    J Nucl Med; 1976 Apr; 17(4):253-7. PubMed ID: 176333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostatic adenocarcinoma: considerations in management.
    Pistenma DA; Bagshaw MA
    Postgrad Med; 1980 Apr; 67(4):135-7, 140-4. PubMed ID: 7367353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial bone scintigraphy for assessing the effectiveness of treatment of osseous metastases from prostatic cancer.
    Langhammer H; Sintermann R; Hör G; Pabst HW
    Nuklearmedizin; 1978 Jul; 17(3):87-91. PubMed ID: 568257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of follow-up bone scans in carcinoma of the prostate.
    Corrie D; Timmons JH; Bauman JM; Thompson IM
    Cancer; 1988 Jun; 61(12):2453-4. PubMed ID: 3130180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone pain in metastatic cancer of prostate.
    Pollen JJ; Schmidt JD
    Urology; 1979 Feb; 13(2):129-34. PubMed ID: 433019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Magnetic resonance imaging for the evaluation of prostate cancer metastatic to bone].
    Fujii Y; Higashi Y; Owada F; Okuno T; Noro A; Arisawa C
    Nihon Hinyokika Gakkai Zasshi; 1995 Jul; 86(7):1261-5. PubMed ID: 7637242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations of bone scanning in clinical oncology.
    Loeffler RK; DiSimone RN; Howland WJ
    JAMA; 1975 Dec; 234(12):1228-32. PubMed ID: 1242747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
    Anand A; Morris MJ; Kaboteh R; Båth L; Sadik M; Gjertsson P; Lomsky M; Edenbrandt L; Minarik D; Bjartell A
    J Nucl Med; 2016 Jan; 57(1):41-5. PubMed ID: 26315832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of current staging procedures in assessing disease extent of prostatic adenocarcinoma.
    J Urol; 1979 Mar; 121(3):300-2. PubMed ID: 430622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some limitations of the radioisotope bone scan in patients with metastatic prostatic cancer. A subanalysis of EORTC trial 30853. The EORTC Urological Group.
    Smith PH; Bono A; Calais da Silva F; Debruyne F; Denis L; Robinson P; Sylvester R; Armitage TG
    Cancer; 1990 Sep; 66(5 Suppl):1009-16. PubMed ID: 2144203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cancer of the prostate: value of bone scintigraphy. Point of view].
    Lumbroso J; Guermazi F; Wibault P; Henry-Amar M; Travagli JP
    Bull Cancer; 1985; 72(5):436-41. PubMed ID: 3907735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution pattern of metastatic bone disease. A need for total body skeletal image.
    Krishnamurthy GT; Tubis M; Hiss J; Blahd WH
    JAMA; 1977 Jun; 237(23):2504-6. PubMed ID: 576963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Positive" bone scan--a contraindication to surgery?
    Basinger GT; McCullough DL; McLaughlin AP
    Urology; 1975 Nov; 6(5):547-53. PubMed ID: 1189142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging for detection of prostate cancer metastatic to bone.
    Turner JW; Hawes DR; Williams RD
    J Urol; 1993 Jun; 149(6):1482-4. PubMed ID: 8501793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.